Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002512:Cephalothin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D046508:Culture Techniques; D004756:Enterobacteriaceae Infections / Q000209:etiology; D005260:Female; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008297:Male; D009268:Nalidixic Acid / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D010403:Penicillin Resistance; D011113:Polymyxins / Q000494:pharmacology; D018805:Sepsis / Q000188:drug therapy; D012706:Serratia marcescens / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism / Q000472:pathogenicity; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011113:Polymyxins; D009268:Nalidixic Acid; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D013752:Tetracycline; D002512:Cephalothin; D013307:Streptomycin